August 16, 2019
CMS on Thursday announced it will require state and federal exchange websites to display quality star ratings for Affordable Care Act exchange plans, starting with the 2020 open enrollment period.
FDA on Thursday unveiled 13 proposed graphic warning labels about the health risks of smoking that, if finalized, would appear on the packaging of all cigarettes sold in the United States. See the proposed warning labels—and what experts are saying about their effectiveness.
Thirteen states and two California counties this week filed lawsuits against the Trump administration's final rule that will allow federal officials to consider whether immigrants are receiving or are likely to receive Medicaid or other public benefits when reviewing their residency applications.
Researchers at Massachusetts General Hospital in a paper that is awaiting publication say they have produced ultra-high-resolution MRIs of a human brain that represent some of the most detailed three-dimensional images of an intact human brain ever to exist.
Planned Parenthood on Wednesday announced it will formally withdraw from the Title X federal family planning program by Aug. 19 unless a federal court blocks a Trump administration rule that bars clinics that receive Title X funding from abortions providing or referring patients to non-emergency abortion care.
American Health Line rounds up the latest health care news in the states.
A federal appeals court on Tuesday reversed a lower court's ruling and reinstated a 2017 rule that changed how CMS calculates Medicaid disproportionate-share hospital payments to ensure providers are not doubly compensated for care costs covered by third-party insurers.
August 15, 2019
While recent headlines proclaimed that exercising in the morning could lead to greater weight loss than exercise at other times in the day, Aaron Carroll, a pediatrician and health care economist, warns that one may want to think twice before overhauling one's workout routine.
FDA on Wednesday approved a new antibiotic, called pretomanid, to treat highly drug-resistant strains of tuberculosis, which kills about 500,000 of the 1.6 million individuals who die annually from the infectious disease.
Advisory Board. All rights reserved.